tobramycin has been researched along with nafcillin in 23 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 16 (69.57) | 18.7374 |
1990's | 4 (17.39) | 18.2507 |
2000's | 3 (13.04) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
Winterbauer, RH | 1 |
Glotzbecker, C; Watanakunakorn, C | 1 |
Shapiro, SA | 1 |
Cohen, E; Gabelman, GS; Karpel, JP; Monane, M | 1 |
Holloway, JJ; Lietman, PS; Moore, RD; Smith, CR | 1 |
Chambers, HF; Miller, RT; Newman, MD | 1 |
Lietman, PS; Moore, RD; Smith, CR | 2 |
Ambinder, RF; Lietman, PS; Mellits, ED; Moore, RD; Smith, CR | 1 |
Berk, SL | 1 |
Fass, RJ; Helsel, VL | 1 |
Ambinder, R; Israel, E; Levitt, R; Lietman, PS; Lipsky, JJ; Longstreth, J; Mellits, ED; Petty, BG; Rocco, L; Smith, CR | 1 |
Alanis, A; Rehm, S; Weinstein, AJ | 1 |
Kinberg, P | 1 |
Lombardi, TP; Lundergan, FS; Neilan, GE; Nightingale, CH | 1 |
Ericsson, C | 1 |
Novick, AC | 1 |
Craig, WA; Gudmundsson, S; Vogelman, B | 1 |
de Araujo, B; Gordon, ES; Holman, J; Webb, LX; Zaccaro, DJ | 1 |
Allen, LV; Stiles, ML | 1 |
6 trial(s) available for tobramycin and nafcillin
Article | Year |
---|---|
Cefotaxime vs nafcillin and tobramycin for the treatment of serious infection. Comparative cost-effectiveness.
Topics: Bacterial Infections; Cefotaxime; Clinical Trials as Topic; Cost-Benefit Analysis; Double-Blind Method; Fees and Charges; Humans; Kidney; Maryland; Nafcillin; Random Allocation; Regression Analysis; Time Factors; Tobramycin | 1986 |
Studies of risk factors for aminoglycoside nephrotoxicity.
Topics: Acute Kidney Injury; Age Factors; Aminoglycosides; Cefotaxime; Clinical Trials as Topic; Double-Blind Method; Humans; Kidney Diseases; Nafcillin; Probability; Risk; Time Factors; Tobramycin | 1986 |
Increased risk of renal dysfunction due to interaction of liver disease and aminoglycosides.
Topics: Aminoglycosides; Anti-Bacterial Agents; Cefotaxime; Double-Blind Method; Female; Humans; Kidney Diseases; Liver Diseases; Male; Middle Aged; Nafcillin; Tobramycin | 1986 |
Lack of evidence for interaction between tobramycin and shock in their effect on renal function.
Topics: Analysis of Variance; Blood Pressure; Clinical Trials as Topic; Creatinine; Double-Blind Method; Humans; Kidney; Nafcillin; Random Allocation; Shock, Septic; Tobramycin | 1985 |
Cefotaxime compared with nafcillin plus tobramycin for serious bacterial infections. A randomized, double-blind trial.
Topics: Adult; Aged; Bacterial Infections; Cefotaxime; Clinical Trials as Topic; Double-Blind Method; Drug Therapy, Combination; Enterobacter; Enterobacteriaceae Infections; Escherichia coli Infections; Female; Humans; Infusions, Parenteral; Kidney Diseases; Male; Middle Aged; Nafcillin; Penicillin Resistance; Prognosis; Pseudomonas Infections; Random Allocation; Tobramycin; Urinary Tract Infections | 1984 |
Comparative efficacy and toxicity of moxalactam and the combination of nafcillin and tobramycin in febrile granulocytopenic patients.
Topics: Agranulocytosis; Clinical Trials as Topic; Drug Therapy, Combination; Female; Fever; Humans; Infections; Male; Moxalactam; Nafcillin; Prospective Studies; Random Allocation; Tobramycin | 1983 |
17 other study(ies) available for tobramycin and nafcillin
Article | Year |
---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Comments on current antibiotic therapy.
Topics: Amikacin; Aminoglycosides; Anti-Bacterial Agents; Bacteria; Bacterial Infections; Clindamycin; Drug Combinations; Gentamicins; Humans; Microbial Sensitivity Tests; Minocycline; Nafcillin; Otorhinolaryngologic Diseases; Sulfamethoxazole; Surgical Procedures, Operative; Ticarcillin; Tobramycin; Trimethoprim | 1979 |
Comparative in vitro activity of nafcillin, oxacillin, and methicillin in combination with gentamicin and tobramycin against enterococci.
Topics: Anti-Bacterial Agents; Drug Synergism; Gentamicins; Methicillin; Nafcillin; Oxacillin; Penicillins; Streptococcus; Tobramycin | 1977 |
Cranioplasty, vertebral body replacement, and spinal fusion with tobramycin-impregnated methylmethacrylate.
Topics: Bacterial Infections; Bone Cements; Cephalosporins; Drug Implants; Follow-Up Studies; Humans; Methylmethacrylate; Methylmethacrylates; Nafcillin; Premedication; Prospective Studies; Prostheses and Implants; Skull; Spinal Fusion; Spine; Tobramycin | 1991 |
Right-sided staphylococcal endocarditis.
Topics: Drug Therapy, Combination; Endocarditis, Bacterial; Humans; Nafcillin; Staphylococcal Infections; Tobramycin; Vancomycin | 1989 |
Right-sided Staphylococcus aureus endocarditis in intravenous drug abusers: two-week combination therapy.
Topics: Adult; Drug Administration Schedule; Drug Therapy, Combination; Endocarditis, Bacterial; Female; Follow-Up Studies; Humans; Injections, Intravenous; Male; Nafcillin; Recurrence; Sepsis; Staphylococcal Infections; Substance-Related Disorders; Tobramycin; Vancomycin | 1988 |
Cefotaxime and nafcillin-tobramycin.
Topics: Bacterial Infections; Cefotaxime; Drug Therapy, Combination; Humans; Nafcillin; Tobramycin | 1985 |
In vitro activity of carumonam.
Topics: Anti-Bacterial Agents; Aztreonam; Clindamycin; Drug Synergism; Enterobacteriaceae; Gram-Negative Aerobic Bacteria; Gram-Positive Bacteria; Microbial Sensitivity Tests; Nafcillin; Piperacillin; Tobramycin | 1985 |
Osteomyelitis of an epiphyseal region.
Topics: Adolescent; Drainage; Drug Therapy, Combination; Follow-Up Studies; Foot Diseases; Humans; Length of Stay; Male; Nafcillin; Osteomyelitis; Pseudomonas Infections; Staphylococcal Infections; Staphylococcus aureus; Ticarcillin; Time Factors; Tobramycin; Toes | 1983 |
Stability of tobramycin sulfate mixed with oxacillin sodium and nafcillin sodium in human serum.
Topics: Drug Combinations; Drug Stability; Nafcillin; Oxacillin; Temperature; Tobramycin | 1984 |
An arm infection after abdominal gunshot wound.
Topics: Abdominal Injuries; Adult; Arm; Cefazolin; Humans; Male; Microbial Sensitivity Tests; Nafcillin; Sepsis; Staphylococcal Infections; Tobramycin; Vancomycin; Wounds, Gunshot | 1981 |
The value of intraoperative antibiotics in preventing renal transplant wound infections.
Topics: Ampicillin; Anti-Bacterial Agents; Cadaver; Clindamycin; Humans; Intraoperative Care; Kidney Transplantation; Nafcillin; Surgical Wound Infection; Tissue Donors; Tobramycin; Transplantation, Homologous | 1981 |
Decreased bactericidal activity during the period of the postantibiotic effect.
Topics: Ampicillin; Bacteria; Bacterial Physiological Phenomena; Cefamandole; Drug Therapy, Combination; Erythromycin; Escherichia coli; Gentamicins; Humans; Klebsiella pneumoniae; Microbial Sensitivity Tests; Nafcillin; Regression Analysis; Rifampin; Staphylococcus aureus; Time Factors; Tobramycin | 1994 |
Antibiotic resistance in staphylococci adherent to cortical bone.
Topics: Anti-Bacterial Agents; Bacterial Adhesion; Bone and Bones; Cefuroxime; Drug Resistance, Microbial; Humans; Methylmethacrylates; Nafcillin; Polytetrafluoroethylene; Staphylococcus; Tobramycin; Vancomycin | 1994 |
Stability of nafcillin sodium, oxacillin sodium, penicillin G potassium, penicillin G sodium, and tobramycin sulfate in polyvinyl chloride drug reservoirs.
Topics: Anti-Bacterial Agents; Drug Stability; Infusion Pumps; Nafcillin; Oxacillin; Penicillin G; Penicillins; Polyvinyl Chloride; Tobramycin | 1997 |